In the last trading session, 1.36 million Conduit Pharmaceuticals Inc (NASDAQ:CDT) shares changed hands as the company’s beta touched 1.94. With the company’s per share price at $2.88 changed hands at $0.37 or 14.74% during last session, the market valuation stood at $2.18M. CDT’s last price was a discount, traded about -63957.29% off its 52-week high of $1844.85. The share price had its 52-week low at $2.21, which suggests the last value was 23.26% up since then. When we look at Conduit Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 0.52 million shares, with the 3-month average coming to 392.20K.

Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information

Instantly CDT was in green as seen at the end of in last trading. With action 25.22%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -99.84%, with the 5-day performance at 25.22% in the green. However, in the 30-day time frame, Conduit Pharmaceuticals Inc (NASDAQ:CDT) is -21.95% down. Looking at the short shares, we see there were 0.1 million shares sold at short interest cover period of 0.22 days.

CDT Dividends

Conduit Pharmaceuticals Inc is expected to release its next quarterly earnings report in July.

Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 18.39% of Conduit Pharmaceuticals Inc shares while 3.63% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 4.45%. There are 3.63% institutions holding the Conduit Pharmaceuticals Inc stock share, with BARCLAYS PLC the top institutional holder. As of 2024-06-30, the company held 0.0015% of the shares, roughly 0.81 million CDT shares worth $0.86 million.

BLACKROCK INC. holds the second largest percentage of outstanding shares, with 0.0012% or 0.69 million shares worth $0.73 million as of 2024-06-30.